IRIX Pharmaceuticals – A Patheon Company

IRIX Pharmaceuticals is a leading small molecule contract research and manufacturing organization (CRMO) helping bring difficult to manufacture APIs to the market.  In February 2014 Averica became their preferred provider for Targeted Isolation services.  This has saved their clients time and money while profiling unknown impurities.  Patheon acquired IRIX in April 2015.